Zacks Investment Research
27 Jul 2026, 15:40 UTC · 10w ago
How Alto Ingredients Plans to Monetize Every Ton of Biogenic CO2
Impact · against what's priced in
ALTO is shifting from treating CO2 as a byproduct to a revenue driver via capacity expansion in Columbia and sequestration studies in Pekin. While these initiatives provide a positive catalysts for growth and risk reduction, they are currently in early execution or evaluation stages.
- ALTO+0.40
No priced-in read yet




